A Knowledge Update on SARS-Coronavirus-2 (SARS-CoV-2)/COVID-19 and Its Global Public Health Implications

Mahendra Pal¹, Gemechu Berhanu Kerorsa² and Venkataramana Kandi^3,

¹Narayan Consultancy on Veterinary Public Health and Microbiology, Anand, India

²College of Agriculture and Veterinary Medicine, Dambi Dollo University, Dambi Dollo, Ethiopia

³Department of Microbiology, Pratima Institute of Medical Sciences, Karimnagar, India

Cite this paper

Mahendra Pal, Gemechu Berhanu Kerorsa and Venkataramana Kandi. A Knowledge Update on SARS-Coronavirus-2 (SARS-CoV-2)/COVID-19 and Its Global Public Health Implications. American Journal of Clinical Medicine Research. 2020; 8(1):23-27. doi: 10.12691/AJCMR-8-1-5

Abstract

The Coronavirus disease 2019 (COVID-19) is a globally declared pandemic viral disease caused by a novel virus, the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) affecting the respiratory tract. This disease has caused high morbidity as well as mortality in susceptible populations throughout the world. Currently, COVID-19 is spreading to most countries of the world including European, American, Asian, and African countries. In these countries, the death rates of the disease have been different. The possible mechanisms of transmission of the disease include droplet inhalation, direct contact with the person infected by the disease, and indirect contact transmission. Common clinical spectrum of the disease includes high fever, dry or productive cough, shortness, and difficulty of breathing, sore throat, general weakness, myalgia, and chills. The disease can be diagnosed using clinical history, travel history, contact history, clinical signs, and different laboratory tests. The emergence of COVID-19 resulted in health, social, economic, and political problems across the globe. There is no single specific antiviral therapy and a vaccine for COVID-19, and the current treatments are almost supportive. Therefore, proper control and preventive measures that include physical/social distancing, washing hands frequently with soap and water, disinfecting hands and objects with sanitizers and alcohol, avoiding contact of contaminated objects, using proper personal protective equipment, and public education could minimize the transmission.

Keywords

COVID-19, Global threat, Pandemic, Public Health, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), control and preventive measures

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.
[2]	Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020; 323(11): 1061-1069.
[3]	Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020; 92(4): 418-423.
[4]	Pal M, Berhanu G, Desalegn C, Kandi V. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020; 12(3): e7423. Published 2020 Mar 26.
[5]	WHO, World Health Organization (2020). Cumulative number of reported probable cases of SARS. https://www.who.int/csr/sars/country/2003_07_11/en/ Last Accessed: May 5, 2020
[6]	Ruffell D. Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic: Q&A with virologist Professor Urs Greber. FEBS Lett. 2020; 594(7): 1127-1131.
[7]	Tang X, Wu C, Li X, Song Y, Yao X, Wu X, Duan Y, Zhang H, Wang Y, Qian Z et al. (2020). On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev, nwaa036.
[8]	Chinese SARS Molecular Epidemiology Consortium (2004) Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303, 1666-1669.
[9]	Muth D, Corman VM, Roth H, Binger T, Dijkman R, Gottula LT, Gloza-Rausch F, Balboni A, Battilani M, Rihtaric D et al. (2018). Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci Rep 8, 15177.
[10]	Rocklov J, Sjodin H and Wilder-Smith A (2020) COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med.
[11]	Perlman S. Another Decade, Another Coronavirus. N Engl J Med. 2020; 382(8): 760-762.
[12]	Orrù G, Ciacchini R, Gemignani A, Conversano C. (2020). Psychological intervention measures during the COVID-19 pandemic. Clinical Neuropsychiatry, 17 (2), 76-79.
[13]	Schwartz DA, Graham AL. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020;12(2):194. Published 2020 Feb 10.
[14]	Coronavirus disease 2019 (COVID-19) Situation Report – 101. https://www.who.int/docs/default-source/coronaviruse/situation- reports/20200430-sitrep-101-covid-19.pdf?sfvrsn=2ba4e093_2 Last Accessed: May 5, 2020.
[15]	Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol. 2010; 84(7): 3134-3146.
[16]	Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1): 11. Published 2020 Mar 13.
[17]	Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci. 2020; 16(10): 1686-1697. Published 2020 Mar 15.
[18]	World Health Organization (WHO). 2010. Limiting the spread of pandemic, zoonotic, and seasonal epidemic influenza. https://www.who.int/influenza/resources/research/research_agend a_influenza_stream_2_limiting_spread.pdf Last Accessed: May 5, 2020.
[19]	Pal, M. Severe Acute Respiratory Syndrome: A Newly Recognized Viral Zoonosis of Public Health Concern. Acta Scientific Microbiology 2018; 1(6): 01.
[20]	Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series [published correction appears in BMJ. 2020 Feb 27;368:m792]. BMJ. 2020;368:m606. Published 2020 Feb 19.
[21]	Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020 Apr 23; 382(17): 1663-1665.
[22]	Xu X, Yu C, Qu J, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020; 47(5): 1275-1280.
[23]	Wu A, Peng Y, Huang B, et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe. 2020; 27(3): 325-328.
[24]	Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3): 105924.
[25]	Zhang J, Xie B, Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis [published online ahead of print, 2020 Apr 22]. Brain Behav Immun. 2020; S0889-1591(20)30589-4.